Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-05-17 Sale | 2024-05-20 5:12 pm | Arcutis Biotherapeutics Inc. | ARQT | Edwards Larry Todd SVP Chief Commercial Officer | 7,640 | $8.9767 | $68,582 | 140,360 (Direct) | View |
2024-05-02 Sale | 2024-05-03 4:29 pm | Arcutis Biotherapeutics Inc. | ARQT | Moore Matthew Richard SVP and Chief Business Officer | 4,681 | $8.7378 | $40,902 | 145,505 (Direct) | View |
2024-05-02 Sale | 2024-05-03 4:22 pm | Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin See Remarks | 13,783 | $8.7378 | $120,433 | 1,091,890 (Indirect Direct) | View |
2024-05-02 Sale | 2024-05-03 4:22 pm | Arcutis Biotherapeutics Inc. | ARQT | Matsuda Masaru See Remark | 5,016 | $8.7378 | $43,829 | 185,408 (Direct) | View |
2024-05-02 Sale | 2024-05-03 4:22 pm | Arcutis Biotherapeutics Inc. | ARQT | Burnett Patrick See Remarks | 9,555 | $8.7378 | $83,490 | 259,745 (Direct) | View |
2024-03-04 Sale | 2024-03-06 5:14 pm | Arcutis Biotherapeutics Inc. | ARQT | Matsuda Masaru See Remark | 3,760 | $11.12 | $41,816 | 190,424 (Direct) | View |
2024-03-04 Sale | 2024-03-06 5:12 pm | Arcutis Biotherapeutics Inc. | ARQT | Burnett Patrick See Remarks | 4,782 | $11.12 | $53,182 | 269,300 (Direct) | View |
2024-03-04 Sale | 2024-03-06 5:09 pm | Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin See Remarks | 14,903 | $11.12 | $165,739 | 1,105,673 (Indirect Direct) | View |
2024-03-04 Sale | 2024-03-06 5:08 pm | Arcutis Biotherapeutics Inc. | ARQT | Moore Matthew Richard SVP and Chief Business Officer | 3,468 | $11.12 | $38,568 | 146,020 (Direct) | View |
2024-03-04 Purchase | 2024-03-06 4:28 pm | Arcutis Biotherapeutics Inc. | ARQT | Heron Patrick J Director | 21,052 | $9.5 | $199,994 | 8,817,666 (Indirect Direct) | View |
2024-02-28 Sale | 2024-03-01 4:11 pm | Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin See Remarks | 2,465 | $10.6 | $26,129 | 1,120,576 (Indirect Direct) | View |
2024-01-02 Sale | 2024-01-03 5:30 pm | Arcutis Biotherapeutics Inc. | ARQT | Burnett Patrick See Remarks | 1,325 | $3.5408 | $4,692 | 57,032 (Direct) | View |
2023-05-31 Purchase | 2023-12-01 8:51 pm | Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin See Remarks | 1,463 | $6.38 | $9,334 | 782,982 (Indirect Direct) | View |
2023-11-21 Sale | 2023-11-21 5:47 pm | Arcutis Biotherapeutics Inc. | ARQT | Matsuda Masaru See Remark | 1,850 | $1.979 | $3,661 | 46,634 (Direct) | View |
2023-10-24 Purchase | 2023-10-26 4:09 pm | Arcutis Biotherapeutics Inc. | ARQT | Frazier Life Sciences VIII L.P. FHM LIFE SCIENCES VIII L.P. FHM LIFE SCIENCES VIII L.L.C. Topper James N Heron Patrick J 10% Owner | 80,000 | $2.5 | $200,000 | 8,827,261 (Indirect Direct) | View |
2023-08-21 Sale | 2023-08-22 12:24 pm | Arcutis Biotherapeutics Inc. | ARQT | Burnett Patrick See Remarks | 1,605 | $7.0419 | $11,302 | 58,357 (Direct) | View |
2023-05-31 Sale | 2023-06-02 8:31 pm | Arcutis Biotherapeutics Inc. | ARQT | Matsuda Masaru See Remark | 1,830 | $7.8023 | $14,278 | 43,609 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-05-16 Option Award | 2024-05-20 5:12 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Edwards Larry Todd SVP Chief Commercial Officer | 60,000 | $0 | 140,360 (Direct) | View |
2024-05-01 Option Award | 2024-05-03 4:29 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Moore Matthew Richard SVP and Chief Business Officer | 4,166 | $0 | 145,505 (Direct) | View |
2024-04-10 Option Award | 2024-04-11 8:32 pm | N/A 2034-04-10 | Arcutis Biotherapeutics Inc. | ARQT | Topper David Joseph Chief Financial Officer | 420,000 | $0 | 420,000 (Direct) | View |
Ownership | 2024-04-11 8:30 pm | N/A 2033-12-18 | Arcutis Biotherapeutics Inc. | ARQT | Topper David Joseph Chief Financial Officer | 0 | $0 | 7,500 (Direct) | View |
2024-02-13 Disposition | 2024-02-15 6:47 pm | N/A 2031-01-19 | Arcutis Biotherapeutics Inc. | ARQT | Moore Matthew Richard SVP and Chief Business Officer | 247,300 | $0 | 149,488 (Direct) | View |
2024-02-13 Option Award | 2024-02-15 6:47 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Moore Matthew Richard SVP and Chief Business Officer | 68,232 | $0 | 149,488 (Direct) | View |
2024-02-13 Disposition | 2024-02-15 6:36 pm | N/A 2030-08-03 | Arcutis Biotherapeutics Inc. | ARQT | Burnett Patrick See Remarks | 451,700 | $0 | 274,082 (Direct) | View |
2024-02-13 Option Award | 2024-02-15 6:36 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Burnett Patrick See Remarks | 189,050 | $0 | 274,082 (Direct) | View |
2024-02-13 Disposition | 2024-02-15 6:32 pm | N/A 2032-01-03 | Arcutis Biotherapeutics Inc. | ARQT | Matsuda Masaru See Remark | 276,100 | $0 | 194,184 (Direct) | View |
2024-02-13 Option Award | 2024-02-15 6:32 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Matsuda Masaru See Remark | 119,550 | $0 | 194,184 (Direct) | View |
2024-02-13 Disposition | 2024-02-15 6:30 pm | N/A 2030-02-27 | Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin See Remarks | 584,500 | $0 | 1,123,041 (Direct) | View |
2024-02-13 Option Award | 2024-02-15 6:30 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin See Remarks | 264,882 | $0 | 1,123,041 (Direct) | View |
2024-02-13 Disposition | 2024-02-15 6:23 pm | N/A 2025-03-31 | Arcutis Biotherapeutics Inc. | ARQT | Smither John W Chief Financial Officer | 34,097 | $0 | 152,757 (Direct) | View |
2024-02-13 Option Award | 2024-02-15 6:23 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Smither John W Chief Financial Officer | 11,365 | $0 | 152,757 (Direct) | View |
2024-01-12 Option Award | 2024-01-17 4:35 pm | N/A 2034-01-12 | Arcutis Biotherapeutics Inc. | ARQT | Burnett Patrick See Remarks | 304,000 | $0 | 361,032 (Direct) | View |
2024-01-12 Option Award | 2024-01-17 4:34 pm | N/A 2034-01-12 | Arcutis Biotherapeutics Inc. | ARQT | Edwards Larry Todd Chief Commercial Officer | 204,000 | $0 | 264,000 (Direct) | View |
2024-01-12 Option Award | 2024-01-17 4:32 pm | N/A 2034-01-12 | Arcutis Biotherapeutics Inc. | ARQT | Matsuda Masaru See Remark | 204,000 | $0 | 250,634 (Direct) | View |
2024-01-12 Option Award | 2024-01-17 4:30 pm | N/A 2034-01-12 | Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin See Remarks | 535,000 | $0 | 1,037,019 (Direct) | View |
2024-01-12 Option Award | 2024-01-17 4:28 pm | N/A 0034-01-12 | Arcutis Biotherapeutics Inc. | ARQT | Moore Matthew Richard SVP and Chief Business Officer | 154,000 | $0 | 180,590 (Direct) | View |
2023-12-20 Gift | 2023-12-22 5:24 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin See Remarks | 6,563 | $0 | 526,432 (Direct) | View |
2023-12-01 Exercise | 2023-12-01 8:51 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin See Remarks | 59,525 | $1.6806 | 782,982 (Direct) | View |
2023-12-01 Exercise | 2023-12-01 8:51 pm | N/A 2029-03-13 | Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin See Remarks | 59,525 | $0 | 782,982 (Direct) | View |
2023-11-18 Option Award | 2023-11-21 5:47 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Matsuda Masaru See Remark | 4,875 | $0 | 46,634 (Direct) | View |
2023-09-27 Option Award | 2023-10-03 9:45 pm | N/A 2033-09-27 | Arcutis Biotherapeutics Inc. | ARQT | Edwards Larry Todd Chief Commercial Officer | 300,000 | $0 | 300,000 (Direct) | View |
2023-08-29 Option Award | 2023-09-12 07:39 am | N/A 2031-01-18 | Arcutis Biotherapeutics Inc. | ARQT | Moore Matthew Richard SVP and Chief Business Officer | 12,500 | $0 | 12,500 (Direct) | View |
2023-08-31 Option Award | 2023-09-05 9:38 pm | N/A 2033-08-31 | Arcutis Biotherapeutics Inc. | ARQT | Smither John W Chief Financial Officer | 125,000 | $0 | 125,000 (Direct) | View |
Ownership | 2023-09-05 9:36 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Smither John W Chief Financial Officer | 0 | $0 | 253,738 (Indirect) | View |
2023-05-27 Option Award | 2023-06-02 8:31 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Matsuda Masaru See Remark | 4,875 | $0 | 43,609 (Direct) | View |
2023-05-31 Option Award | 2023-06-02 8:31 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Matsuda Masaru See Remark | 1,463 | $6.38 | 43,609 (Direct) | View |
2023-05-31 Option Award | 2023-06-02 7:22 pm | N/A 2033-05-31 | Arcutis Biotherapeutics Inc. | ARQT | LIN SUE-JEAN Director | 16,595 | $0 | 21,207 (Direct) | View |
2023-05-31 Option Award | 2023-06-02 7:16 pm | N/A 2033-05-31 | Arcutis Biotherapeutics Inc. | ARQT | Heron Patrick J Director 10% Owner | 16,595 | $0 | 20,907 (Direct) | View |
2023-05-31 Option Award | 2023-06-02 7:13 pm | N/A 2033-05-31 | Arcutis Biotherapeutics Inc. | ARQT | CHAUDHURI BHASKAR Director | 16,595 | $0 | 912,279 (Direct) | View |
2023-05-31 Option Award | 2023-06-02 7:10 pm | N/A 2033-05-31 | Arcutis Biotherapeutics Inc. | ARQT | Curran Terrie Director | 16,595 | $0 | 20,907 (Direct) | View |
2023-05-31 Option Award | 2023-06-02 7:08 pm | N/A 2033-05-31 | Arcutis Biotherapeutics Inc. | ARQT | Gilbert Halley E Director | 16,595 | $0 | 20,907 (Direct) | View |